SlideShare a Scribd company logo
1 of 40
Drug
Body /
Living system
Actions of a drug on the body.
( Pharmacodynamics )
Actions of the body on the drugs
( Pharmacokinetics )
FARMAKOKINETIK
 ABSORPSI
 Distribusi
 Biotransformasi
Ekskresi
Asorpsi
Distribusi
Biotransformasi
Ekskresi
Terikat protein
bebas
Faktor yang mempengaruhi
absorpsi
• Makanan:
-rifampicin
-phenoxymethyl penicillin
-erythromycin
• Obat lain:
-Antacid
-Anticholinergic
-Metoclopramide
• Penyakit saluran cerna/operasi
Digoxin : jumlah dalam tubuh 500 mcg
Konsentrasi dl. Plasma 0,78 mcg / L
500
Vd = = 641 L
0, 78
Quinacrine Vd 50.000 L
Frusemid Vd 7 L
Kloroquin Retina, hati
Tetrasiklin Tulang, hati
Digoxin Ginjal, hati, jantung
Eradication of S.pneumoniae
• It is suggested that AUIC values for successful
pneumococcal eradication and prevention of
resistant development vary from 60 -250
• So the older quinolone such as ciprofloxacin or
levofloxacin are insufficient for eradication
• Moxifloxacin & gemifloxacin have sufficiently
high AUIC value (>150)
Dosis ulang & konsentrasi steady state
• Bila interval pemberian obat > t ½
• Bila interval pemberian obat < t ½
• Bila interval pemberian obat = t ½
Biotransformasi
Obat yang larut dl. air
Obat yang larut dalam
lipid
Hati
Saluran cerna
Paru ekskresi
Biotransformasi fase I / Asintetik
–Oksidasi (cytochrome P450)
–Reduksi
–Hidrolisis
–Deamination
Biotransformasi fase II / Sintetik
konyugasi dengan :
Asam glucuronic
Asam asetat (Acetylation)
Glycin
Asam sulfat
Glutamin
Induksi Enzym / Enzyme inducer
o Barbiturate :Barbiturate
Coumarin
Pil kontrasepsi
o Phenytoin : Dexamethasone
Pil kontrasepsi
o Merokok : Nicotine
(Nicotine ) Pil kontrasepsi
Theophyllin
o Rifampicin : Pil kontrasepsi
Enzyme Inhibitor / inhibisi enzim
o Chloramphenicol Phenytoin
Tolbutamide
o Cimetidine Chlordiazepoxide
Diazepam
Chlorazepate
Phenytoin
Theophyllin
Ekskresi lewat ginjal
• Filtrasi glomerulus
• Sekresi tubulus
• Reabsorpsi
Phenobarbital
• Warfarin
• Diazepam
Aplikasi farmakokinetik dalam klinik
• Menentukan loading dose
-Antibiotic
-Anticoagulant
-Antiepileptic
-Antiarrhythmic
-Antiasthmatic
-Antihypertensive
• Menentukan maintenance dose
• Merencanakan interval dose
Contoh menghitung loading dose
• Seorang pasien memerlukan Metronidazole
Mean Effective Concentration 6,25-8 mcg/ml (konsentrasi terapi)
Bioavailability (i.v=1, oral=95%, rectal=80%
Plasma half-life (t ½ )= 10 jam
Vd = 1L/kgBB
Berapa Loading dose i.v, atau rectal yang diberikan bila BB pasien
60 kg?
Berapa maintenance dose untuk setiap 8 jam, untuk pasien BB 60
kg, kalau diberikan peroral atau perectal?
Jawaban
• Loading dose = Vd x Cp / F
Vd = Volume of distribution
Cp = Konsentrasi terapi dalam plasma
F = Bioavailability
Loading dose i.v = 60 L x 6,25 mg/L /1
= 375 mg.
Loading dose oral = 60 L x 6,25 mg/L / 0,95
= 394 mg.
Loading dose rectal = 60 L x 6,25 mg/L / 0,60
= 625 mg.
Calculation of a maintenance dose:
-identikasi konsentrasi terapi
-penentuan dosis untuk maintenance
-penentuan interval dosis (setiap 8 jam, 6 jam dlsb)
• Maintenance dose = Vd x Cp x Di x 0,693 / t ½
-------------------------
F
Vd = Volume of distribution
Cp = Konsentrasi terapi
Di = Drug interval (interval dosis)
F = Bioavailability
• Maintenance dose oral tiap 8 jam untuk pasien 60 kg =
Vd x Cp x Di x 0,693 / t ½
----------------------
F
= 60L x 6,25/L x 8 x 0,693 / 10
-------------------------
0,95
= 218,8 mg
Disease and drug dosing
• Dosis obat perlu diubah bila:
. Obat > 80% dieliminasi oleh satu organ saja
(ginjal saja, atau hepar saja)
. Safety margin (IT) obat sempit
(lithium, digoxin, theophylline)
Dosage in patient with renal impairment
• Standard loading dose
Patient’s CC
• Corrected dose = normal dose x --------------------
Normal CC (100 mL/min)
Corrected dose of drug with 2 route
of elimination (renal and liver)
• If a drug is cleared 50% by kidney, and 50% by liver. In
this patient the liver function is normal, but the function of
kidney is impaired with CC 20 mL/min. The normal
dosage is 200 mg/day.
• So the hepatic and renal clearance are each 100 mg/day
20 mL/min
• Corrected dose= 100 mg/day + 100 mg/day x-------------
100 mL/min
Dosage in liver disease
Tergantung BSP retention
• BSP retention < 5% (No Liver Damage)
• BSP retention 5-25% (Mild Liver Damage)
dosis maintenance dikurangi 25-50%
• BSP retention 25-75% (Severe Liver Damage)
dosis mainenance dikurangi 50-80%
• BSP retention >75% (Very Severe Liver Damage)
dosis maintenance dikurangi 80%
Drug dosing in the elderly
• Alter the Volume of distribution (Vd)
• Decline in cardiac output
• Decline in renal clearance
• Decline in hepatic extraction
• Decline in protein binding
• Disease in elderly
Reduction drug dose in elderly:
Digoxin Cimetidine Benzodiazepine
Gentamycin Tobramycin L-dopa
Phenytoin Valproate
Pethidine TCA
Farmakokinetik sm. iv

More Related Content

Similar to Farmakokinetik sm. iv

nutrition in ICU part 2. (Total parenteral nutrition)
nutrition in ICU part 2.   (Total parenteral nutrition)nutrition in ICU part 2.   (Total parenteral nutrition)
nutrition in ICU part 2. (Total parenteral nutrition)charul jakhwal
 
SBP (National Hepatic Institute)
SBP (National Hepatic Institute)SBP (National Hepatic Institute)
SBP (National Hepatic Institute)Mohamed Moustafa
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapyJoginder Singh
 
Hepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptxHepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptxSudiptaBera9
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Kevin John
 
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfSabariKreeshan
 
Tpn by dr. aakif
Tpn by dr. aakifTpn by dr. aakif
Tpn by dr. aakifdraakif
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxSaishDalvi
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationhttp://neigrihms.gov.in/
 
HepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdfHepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdfHelena949653
 
CRRT-f
CRRT-fCRRT-f
CRRT-fGBKwak
 
Peritoneal dialysis
Peritoneal dialysisPeritoneal dialysis
Peritoneal dialysisAjay Kurian
 
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsPharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsBhaswat Chakraborty
 
Cisplatin (Anti-cancer Drug)
Cisplatin (Anti-cancer Drug)Cisplatin (Anti-cancer Drug)
Cisplatin (Anti-cancer Drug)AsthaNeupane
 

Similar to Farmakokinetik sm. iv (20)

Digoxin
DigoxinDigoxin
Digoxin
 
nutrition in ICU part 2. (Total parenteral nutrition)
nutrition in ICU part 2.   (Total parenteral nutrition)nutrition in ICU part 2.   (Total parenteral nutrition)
nutrition in ICU part 2. (Total parenteral nutrition)
 
SBP (National Hepatic Institute)
SBP (National Hepatic Institute)SBP (National Hepatic Institute)
SBP (National Hepatic Institute)
 
Parenteral nutrition therapy
Parenteral nutrition therapyParenteral nutrition therapy
Parenteral nutrition therapy
 
Hepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptxHepatic Considerations In Oral Surgery .pptx
Hepatic Considerations In Oral Surgery .pptx
 
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease. Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
Dose Adjustment in Acute Renal Failure and Chronic Kidney Disease.
 
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdfANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
ANAESTHESIA FOR PATIENT WITH LIVER DISEASE.pdf
 
Tpn by dr. aakif
Tpn by dr. aakifTpn by dr. aakif
Tpn by dr. aakif
 
Dosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptxDosage regimen in renal failure ( Neha Mayekar).pptx
Dosage regimen in renal failure ( Neha Mayekar).pptx
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of elimination
 
HepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdfHepaticDosageAdjustment.pdf
HepaticDosageAdjustment.pdf
 
management of SLE.pptx
management of SLE.pptxmanagement of SLE.pptx
management of SLE.pptx
 
CRRT-f
CRRT-fCRRT-f
CRRT-f
 
Dvt prophalaxis
Dvt prophalaxisDvt prophalaxis
Dvt prophalaxis
 
Voclosporin journal club
Voclosporin journal clubVoclosporin journal club
Voclosporin journal club
 
Peritoneal dialysis
Peritoneal dialysisPeritoneal dialysis
Peritoneal dialysis
 
Pharmacokinetics and Pharmacodynamics
Pharmacokinetics and PharmacodynamicsPharmacokinetics and Pharmacodynamics
Pharmacokinetics and Pharmacodynamics
 
Cisplatin (Anti-cancer Drug)
Cisplatin (Anti-cancer Drug)Cisplatin (Anti-cancer Drug)
Cisplatin (Anti-cancer Drug)
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
septic shock presentation. a majot threat to Surgeon
septic shock presentation. a majot threat to Surgeonseptic shock presentation. a majot threat to Surgeon
septic shock presentation. a majot threat to Surgeon
 

Recently uploaded

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 

Recently uploaded (20)

The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 

Farmakokinetik sm. iv

  • 1.
  • 2. Drug Body / Living system Actions of a drug on the body. ( Pharmacodynamics ) Actions of the body on the drugs ( Pharmacokinetics )
  • 3. FARMAKOKINETIK  ABSORPSI  Distribusi  Biotransformasi Ekskresi Asorpsi Distribusi Biotransformasi Ekskresi Terikat protein bebas
  • 4.
  • 5.
  • 6.
  • 7. Faktor yang mempengaruhi absorpsi • Makanan: -rifampicin -phenoxymethyl penicillin -erythromycin • Obat lain: -Antacid -Anticholinergic -Metoclopramide • Penyakit saluran cerna/operasi
  • 8.
  • 9.
  • 10. Digoxin : jumlah dalam tubuh 500 mcg Konsentrasi dl. Plasma 0,78 mcg / L 500 Vd = = 641 L 0, 78 Quinacrine Vd 50.000 L Frusemid Vd 7 L Kloroquin Retina, hati Tetrasiklin Tulang, hati Digoxin Ginjal, hati, jantung
  • 11.
  • 12.
  • 13.
  • 14. Eradication of S.pneumoniae • It is suggested that AUIC values for successful pneumococcal eradication and prevention of resistant development vary from 60 -250 • So the older quinolone such as ciprofloxacin or levofloxacin are insufficient for eradication • Moxifloxacin & gemifloxacin have sufficiently high AUIC value (>150)
  • 15.
  • 16.
  • 17.
  • 18. Dosis ulang & konsentrasi steady state • Bila interval pemberian obat > t ½ • Bila interval pemberian obat < t ½ • Bila interval pemberian obat = t ½
  • 19.
  • 20. Biotransformasi Obat yang larut dl. air Obat yang larut dalam lipid Hati Saluran cerna Paru ekskresi
  • 21. Biotransformasi fase I / Asintetik –Oksidasi (cytochrome P450) –Reduksi –Hidrolisis –Deamination Biotransformasi fase II / Sintetik konyugasi dengan : Asam glucuronic Asam asetat (Acetylation) Glycin Asam sulfat Glutamin
  • 22.
  • 23.
  • 24.
  • 25. Induksi Enzym / Enzyme inducer o Barbiturate :Barbiturate Coumarin Pil kontrasepsi o Phenytoin : Dexamethasone Pil kontrasepsi o Merokok : Nicotine (Nicotine ) Pil kontrasepsi Theophyllin o Rifampicin : Pil kontrasepsi
  • 26. Enzyme Inhibitor / inhibisi enzim o Chloramphenicol Phenytoin Tolbutamide o Cimetidine Chlordiazepoxide Diazepam Chlorazepate Phenytoin Theophyllin
  • 27. Ekskresi lewat ginjal • Filtrasi glomerulus • Sekresi tubulus • Reabsorpsi Phenobarbital • Warfarin • Diazepam
  • 28.
  • 29. Aplikasi farmakokinetik dalam klinik • Menentukan loading dose -Antibiotic -Anticoagulant -Antiepileptic -Antiarrhythmic -Antiasthmatic -Antihypertensive • Menentukan maintenance dose • Merencanakan interval dose
  • 30. Contoh menghitung loading dose • Seorang pasien memerlukan Metronidazole Mean Effective Concentration 6,25-8 mcg/ml (konsentrasi terapi) Bioavailability (i.v=1, oral=95%, rectal=80% Plasma half-life (t ½ )= 10 jam Vd = 1L/kgBB Berapa Loading dose i.v, atau rectal yang diberikan bila BB pasien 60 kg? Berapa maintenance dose untuk setiap 8 jam, untuk pasien BB 60 kg, kalau diberikan peroral atau perectal?
  • 31. Jawaban • Loading dose = Vd x Cp / F Vd = Volume of distribution Cp = Konsentrasi terapi dalam plasma F = Bioavailability Loading dose i.v = 60 L x 6,25 mg/L /1 = 375 mg. Loading dose oral = 60 L x 6,25 mg/L / 0,95 = 394 mg. Loading dose rectal = 60 L x 6,25 mg/L / 0,60 = 625 mg.
  • 32. Calculation of a maintenance dose: -identikasi konsentrasi terapi -penentuan dosis untuk maintenance -penentuan interval dosis (setiap 8 jam, 6 jam dlsb) • Maintenance dose = Vd x Cp x Di x 0,693 / t ½ ------------------------- F Vd = Volume of distribution Cp = Konsentrasi terapi Di = Drug interval (interval dosis) F = Bioavailability
  • 33. • Maintenance dose oral tiap 8 jam untuk pasien 60 kg = Vd x Cp x Di x 0,693 / t ½ ---------------------- F = 60L x 6,25/L x 8 x 0,693 / 10 ------------------------- 0,95 = 218,8 mg
  • 34. Disease and drug dosing • Dosis obat perlu diubah bila: . Obat > 80% dieliminasi oleh satu organ saja (ginjal saja, atau hepar saja) . Safety margin (IT) obat sempit (lithium, digoxin, theophylline)
  • 35.
  • 36. Dosage in patient with renal impairment • Standard loading dose Patient’s CC • Corrected dose = normal dose x -------------------- Normal CC (100 mL/min)
  • 37. Corrected dose of drug with 2 route of elimination (renal and liver) • If a drug is cleared 50% by kidney, and 50% by liver. In this patient the liver function is normal, but the function of kidney is impaired with CC 20 mL/min. The normal dosage is 200 mg/day. • So the hepatic and renal clearance are each 100 mg/day 20 mL/min • Corrected dose= 100 mg/day + 100 mg/day x------------- 100 mL/min
  • 38. Dosage in liver disease Tergantung BSP retention • BSP retention < 5% (No Liver Damage) • BSP retention 5-25% (Mild Liver Damage) dosis maintenance dikurangi 25-50% • BSP retention 25-75% (Severe Liver Damage) dosis mainenance dikurangi 50-80% • BSP retention >75% (Very Severe Liver Damage) dosis maintenance dikurangi 80%
  • 39. Drug dosing in the elderly • Alter the Volume of distribution (Vd) • Decline in cardiac output • Decline in renal clearance • Decline in hepatic extraction • Decline in protein binding • Disease in elderly Reduction drug dose in elderly: Digoxin Cimetidine Benzodiazepine Gentamycin Tobramycin L-dopa Phenytoin Valproate Pethidine TCA